IRVSX | VIVIX | IRVSX / VIVIX | |
Total Expense Ratio | 0.59 | 0.04 | 1,475% |
Annual Report Gross Expense Ratio | 0.69 | 0.04 | 1,725% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | -12.561 | 6.533 | -192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 275M | 196B | 0% |
Annual Yield % from dividends | 5.73 | 2.19 | 262% |
Returns for 1 year | -10.38 | 7.91 | -131% |
Returns for 3 years | 5.08 | 25.93 | 20% |
Returns for 5 years | 40.30 | 68.54 | 59% |
Returns for 10 years | 65.99 | 114.61 | 58% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CNWFX | 89.75 | 0.19 | +0.21% |
American Funds New World 529F | |||
RSYEX | 59.65 | 0.08 | +0.13% |
Victory RS Small Cap Growth Y | |||
GGICX | 13.23 | N/A | N/A |
Goldman Sachs Global Infras C | |||
HIBCX | 55.40 | -0.02 | -0.04% |
Hartford Capital Appreciation HLS IB | |||
SAMVX | 12.20 | -0.09 | -0.73% |
Virtus Ceredex Mid-Cap Value Equity A |